Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $411.77 million. The enterprise value is $377.77 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 17.30 million shares outstanding. The number of shares has increased by 9.53% in one year.
| Current Share Class | 17.30M |
| Shares Outstanding | 17.30M |
| Shares Change (YoY) | +9.53% |
| Shares Change (QoQ) | -1.25% |
| Owned by Insiders (%) | 1.00% |
| Owned by Institutions (%) | 47.73% |
| Float | 14.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.81 |
| Forward PS | 9.31 |
| PB Ratio | 21.49 |
| P/TBV Ratio | 29.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 13.59.
| Current Ratio | 3.24 |
| Quick Ratio | 3.11 |
| Debt / Equity | 13.59 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.07 |
Financial Efficiency
Return on equity (ROE) is -189.46% and return on invested capital (ROIC) is -31.27%.
| Return on Equity (ROE) | -189.46% |
| Return on Assets (ROA) | -26.80% |
| Return on Invested Capital (ROIC) | -31.27% |
| Return on Capital Employed (ROCE) | -75.46% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | -$2.18M |
| Employee Count | 61 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -152,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.74% in the last 52 weeks. The beta is 0.95, so NKTR's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +11.74% |
| 50-Day Moving Average | 14.55 |
| 200-Day Moving Average | 14.61 |
| Relative Strength Index (RSI) | 61.65 |
| Average Volume (20 Days) | 4,830,802 |
Short Selling Information
The latest short interest is 1.22 million, so 7.03% of the outstanding shares have been sold short.
| Short Interest | 1.22M |
| Short Previous Month | 595,786 |
| Short % of Shares Out | 7.03% |
| Short % of Float | 8.16% |
| Short Ratio (days to cover) | 2.36 |
Income Statement
In the last 12 months, NKTR had revenue of $87.25 million and -$133.04 million in losses. Loss per share was -$9.52.
| Revenue | 87.25M |
| Gross Profit | 65.10M |
| Operating Income | -139.83M |
| Pretax Income | -177.16M |
| Net Income | -133.04M |
| EBITDA | -136.62M |
| EBIT | -139.83M |
| Loss Per Share | -$9.52 |
Full Income StatementBalance Sheet
The company has $218.63 million in cash and $186.66 million in debt, giving a net cash position of $33.99 million or $1.96 per share.
| Cash & Cash Equivalents | 218.63M |
| Total Debt | 186.66M |
| Net Cash | 33.99M |
| Net Cash Per Share | $1.96 |
| Equity (Book Value) | 13.74M |
| Book Value Per Share | 1.11 |
| Working Capital | 158.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$176.87 million and capital expenditures -$1.31 million, giving a free cash flow of -$178.19 million.
| Operating Cash Flow | -176.87M |
| Capital Expenditures | -1.31M |
| Free Cash Flow | -178.19M |
| FCF Per Share | -$10.30 |
Full Cash Flow StatementMargins
Gross margin is 74.61%, with operating and profit margins of -160.27% and -152.49%.
| Gross Margin | 74.61% |
| Operating Margin | -160.27% |
| Pretax Margin | -152.66% |
| Profit Margin | -152.49% |
| EBITDA Margin | -156.59% |
| EBIT Margin | -160.27% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.53% |
| Shareholder Yield | -9.53% |
| Earnings Yield | -32.31% |
| FCF Yield | -43.27% |
Analyst Forecast
The average price target for NKTR is $81.67, which is 243.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $81.67 |
| Price Target Difference | 243.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 2.66% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
NKTR has an Altman Z-Score of -20.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -20.1 |
| Piotroski F-Score | 3 |
